These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8298139)

  • 21. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
    Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
    Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
    Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
    Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line.
    Gkiafi Z; Panayotou G
    J Proteome Res; 2011 Jul; 10(7):2959-68. PubMed ID: 21615174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
    Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
    J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
    Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG
    Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
    Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
    Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
    Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H
    Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line.
    Koliais S; Bjursell G; Adams A; Lindahl T; Klein G
    J Natl Cancer Inst; 1978 May; 60(5):991-4. PubMed ID: 205666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
    Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
    J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization.
    Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J
    Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
    Shimizu N; Tanabe-Tochikura A; Kuroiwa Y; Takada K
    J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
    Razzouk BI; Srinivas S; Sample CE; Singh V; Sixbey JW
    J Infect Dis; 1996 Mar; 173(3):529-35. PubMed ID: 8627013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
    Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
    Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.